⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BDTX News
Black Diamond Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
BDTX
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
BDTX
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
BDTX
Cancer Stress Protein Helps Tumors Hide From Immunity
prnewswire.com
PFE
BMY
KYMR
AGIO
BDTX
PRTA
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
AVBP
SMMT
MRUS
MRK
GNPX
CGEM
ABBV
BMY
BDTX
LTRN
PFE
JNJ
LLY
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer
businesswire.com
BDTX
BSX
Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030 USA - English USA - English USA - Français
prnewswire.com
BDTX
Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM
globenewswire.com
BDTX
Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update
globenewswire.com
BDTX